The Vigabatrin REMS Program is needed by the FDA to make sure notified risk-benefit choices prior to starting treatment, and to make sure suitable use of vigabatrin while individuals are treated. When vision loss will happen, it is not possible for your healthcare company to know.
One of the most common side effect of SABRIL in children 3 to 16 years is weight gain. With severe vision loss, you might just be able to see points directly before you (often called tunnel vision"). You go to danger for vision loss with any kind of amount of SABRIL.
Tell your doctor if you are expectant or plan to get expecting. If vision screening can not be done, your healthcare provider might continue suggesting SABRIL, however will not have the ability to expect any kind of vision loss. Your medical care supplier might stop recommending SABRIL for you (or your child)if vision tests are not done regularly.